Torben Moos

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Iron Deficiency

Top Venues

Journal of neurochemistry

Molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Steinunn Sara Helgudottir, Kasper Bendix Johnsen, Lisa Greve Routhe, Charlotte Laurfelt Munch Rasmussen, Maj Schneider Thomsen, Torben Moos
Upregulation of Transferrin Receptor 1 (TfR1) but Not Glucose Transporter 1 (GLUT1) or CD98hc at the Blood-Brain Barrier in Response to Valproic Acid. Cells 13 (14) (2024)
Steinunn Sara Helgudottir, Kasper Bendix Johnsen, Lisa Greve Routhe, Charlotte Laurfelt Munch Rasmussen, Maj Schneider Thomsen, Torben Moos
Upregulation of Transferrin Receptor 1 (TfR1) but Not Glucose Transporter 1 (GLUT1) or CD98hc at the Blood-Brain Barrier in Response to Valproic Acid. Cells 13 (14) (2024)
Steinunn Sara Helgudottir, Kasper Bendix Johnsen, Lisa Greve Routhe, Charlotte Laurfelt Munch Rasmussen, Maj Schneider Thomsen, Torben Moos
Upregulation of Transferrin Receptor 1 (TfR1) but Not Glucose Transporter 1 (GLUT1) or CD98hc at the Blood-Brain Barrier in Response to Valproic Acid. Cells 13 (14) (2024)
Pawel Stocki, Jaroslaw Szary, Mykhaylo Demydchuk, Leandra Northall, Charlotte L M Rasmussen, Diana Bahu Logan, Aziz Gauhar, Laura Thei, Shu-Fen Coker, Torben Moos, Frank S Walsh, J Lynn Rutkowski
CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration. Pharmaceutics 15 (3) (2023)
Pawel Stocki, Jaroslaw Szary, Mykhaylo Demydchuk, Leandra Northall, Charlotte L M Rasmussen, Diana Bahu Logan, Aziz Gauhar, Laura Thei, Shu-Fen Coker, Torben Moos, Frank S Walsh, J Lynn Rutkowski
CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration. Pharmaceutics 15 (3) (2023)
Pawel Stocki, Jaroslaw Szary, Mykhaylo Demydchuk, Leandra Northall, Charlotte L M Rasmussen, Diana Bahu Logan, Aziz Gauhar, Laura Thei, Shu-Fen Coker, Torben Moos, Frank S Walsh, J Lynn Rutkowski
CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration. Pharmaceutics 15 (3) (2023)
Louise Berkhoudt Lassen, Maj Schneider Thomsen, Elisa Basso, Ernst-Martin Füchtbauer, Annette Füchtbauer, Tiago Fleming Outeiro, Poul Henning Jensen, Torben Moos
Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells 11 (22) (2022)
Maj Schneider Thomsen, Kasper Bendix Johnsen, Krzysztof Kucharz, Martin Lauritzen, Torben Moos
Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles. Pharmaceutics 14 (10) (2022)
Charlotte Laurfelt Munch Rasmussen, Eva Hede, Lisa Greve Routhe, Jakob Körbelin, Steinunn Sara Helgudottir, Louiza Bohn Thomsen, Markus Schwaninger, Annette Burkhart, Torben Moos
A novel strategy for delivering Niemann-Pick type C2 proteins across the blood-brain barrier using the brain endothelial-specific AAV-BR1 virus. Journal of neurochemistry (2022)
Maj Schneider Thomsen, Nanna Humle, Eva Hede, Torben Moos, Annette Burkhart, Louiza Bohn Thomsen
The blood-brain barrier studied in vitro across species. PloS one 16 (3) (2021)
Jonas Ellegaard Nielsen, Kamilla Sofie Pedersen, Karsten Vestergård, Raluca Georgiana Maltesen, Gunna Christiansen, Søren Lundbye-Christensen, Torben Moos, Søren Risom Kristensen, Shona Pedersen
Novel Blood-Derived Extracellular Vesicle-Based Biomarkers in Alzheimer's Disease Identified by Proximity Extension Assay. Biomedicines 8 (7) (2020)
Steinunn Sara Helgudottir, Lisa J Routhe, Annette Burkhart, Katrine Jønsson, Inge S Pedersen, Jacek Lichota, Torben Moos
Epigenetic Regulation of Ferroportin in Primary Cultures of the Rat Blood-Brain Barrier. Molecular neurobiology 57 (8) (2020)
Eva Hede, Christine B Christiansen, Christian W Heegaard, Torben Moos, Annette Burkhart
Gene therapy to the blood-brain barrier with resulting protein secretion as a strategy for treatment of Niemann Picks type C2 disease. Journal of neurochemistry 156 (3) (2020)
Veronika Markova, Charlotte Holm, Anja Bisgaard Pinborg, Lars Lykke Thomsen, Torben Moos
Impairment of the Developing Human Brain in Iron Deficiency: Correlations to Findings in Experimental Animals and Prospects for Early Intervention Therapy. Pharmaceuticals (Basel, Switzerland) 12 (3) (2019)
Louiza Bohn Thomsen, Thomas Linemann, Svend Birkelund, Gitte Abildgaard Tarp, Torben Moos
Evaluation of Targeted Delivery to the Brain Using Magnetic Immunoliposomes and Magnetic Force. Materials (Basel, Switzerland) 12 (21) (2019)
Steinunn Sara Helgudottir, Jacek Lichota, Annette Burkhart, Torben Moos
Hepcidin Mediates Transcriptional Changes in Ferroportin mRNA in Differentiated Neuronal-Like PC12 Cells Subjected to Iron Challenge. Molecular neurobiology 56 (4) (2018)